Your cart (0)

Shopping Cart Is Empty
Subtotal: 0.00

Board of Directors

JMI Syringes & Medical Devices Limited

Mr. Md. Jabed Iqbal Pathan
Chairman
Mr. Md. Jabed Iqbal Pathan
Chairman — Board of Directors

A highly accomplished entrepreneur and visionary leader in Bangladesh, Engr. Md. Jabed Iqbal Pathan has built a distinguished career spanning more than 27 years in business, establishing a powerful presence in the medical and pharmaceutical sectors. Engr. Pathan completed his B.Sc. Engineering degree from the prestigious Bangladesh University of Engineering and Technology (BUET). Following his graduation, he quickly transitioned his technical expertise into a successful business career, engaging with various organizations at different capacities.

He currently serves as a Director and Chairman of the Board of Directors of JMI Syringes & Medical Devices Limited, where he guides strategic growth and operational excellence. His influence extends far beyond JMI; he is the founder and Director of a diverse portfolio of successful businesses, including key joint ventures and essential service providers:

  • Nipro JMI Pharma Ltd.
  • Nipro JMI Medical Ltd.
  • Unido Pharmaceuticals Ltd.
  • Mazzak Inter Trade Ltd.
  • Tracking & Survey Solution Ltd.
  • DNA Solution Ltd.
  • 3i Securities Ltd.

Widely recognized as a well-known figure in the Bangladeshi business community, Engr. Pathan's extensive experience and commitment to founding and leading multiple enterprises underscore his position as a driving force behind key industry developments.

Mr. Md. Abdur Razzaq
Managing Director
Mr. Md. Abdur Razzaq
Managing Director (CIP)

Mr. Md. Abdur Razzaq is a highly respected entrepreneur and the visionary founder of the JMI Group of Industries, one of Bangladesh's most renowned and diversified conglomerates. Under his leadership, the JMI Group has grown to encompass 35 companies operating across multiple key sectors. A distinguished alumnus of Chittagong University, where he earned both his undergraduate and postgraduate degrees in Economics, Mr. Razzaq is a proven leader with vast experience in high-level positions, including a significant tenure in the private sector of Japan.

As the Founder and Managing Director of JMI Syringes & Medical Devices Ltd., he spearheaded the establishment and growth of a critical component of the Group. His founding influence extends to a wide array of successful JMI Group enterprises:

Pharmaceutical & Medical
  • NIPRO JMI Company Ltd.
  • NIPRO JMI Pharma Ltd.
  • JMI Hospital Requisite Manufacturing Ltd.
  • JMI Vaccine Ltd.
  • Nipro JMI Dialysis Centre Ltd.
Infrastructure & Energy
  • JMI Builders and Construction Ltd.
  • JMI CNG Dispensing Ltd.
  • JMI Industrial Gas Ltd.
  • JMI LPG & Petroleum Ltd.
  • JMI Cylinders Ltd.
  • JMI Hollow Block Co. Ltd.
Manufacturing & Services
  • JMI Printing & Packaging Ltd.
  • JMI Safe Transportation Ltd.
  • JMI Export & Import Co. Ltd.
  • JMI Engineering Ltd.
  • JMI Sankur Valve & Bung Ltd.
  • JMI Sankur Auto Tank Ltd.
  • JMI Sonlu Appliance Ltd.
  • Sunmyung International (Pvt.) Ltd.
Research & Finance
  • Sunrise Research & Consultancy Ltd.
  • JMI Industrial Research & Toxicology Ltd.
  • Bangladesh Clinical Trials Ltd.
  • 3i Securities Ltd.

Mr. Razzaq's exceptional success and invaluable contributions to the national economy have been recognized by the government of Bangladesh. He is a multiple-time recipient of the prestigious CIP (Commercially Important Person) award, securing the honor in 2015, 2017, and most recently in 2023.

Mr. Hoi Kwan Kim
Director
Mr. Hoi Kwan Kim
Director

Mr. Hoi Kwan Kim is a highly experienced international business leader and an expert in the medical and surgical devices sector, bringing more than 36 years of specialized experience to the JMI Group. Mr. Kim holds an MBA and serves as the Managing Director of two key Korean enterprises: Sun Myung International Inc. and Sun Myung Engineering Corporation.

His extensive expertise and global perspective are critical assets to the JMI Group, where he holds Director positions in several key Bangladeshi companies:

  • JMI Syringes & Medical Devices Ltd.
  • NIPRO JMI Company Ltd.
  • JMI Hospital Requisite Mfg. Ltd.
  • JMI Vaccine Ltd.
  • JMI CNG Dispensing Ltd.
  • JMI Hollow Block Co. Ltd.
  • JMI Printing & Packaging Ltd.

With a significant commercial footprint that extends beyond his base in South Korea, Mr. Kim manages business operations across Asia, including in Bangladesh, Pakistan, China, Vietnam, Singapore, and Taiwan. His deep international acumen ensures the JMI Group maintains a world-class standard in its operations and strategic partnerships.

Mr. Toshikazu Tazawa
Nominee Director
Mr. Toshikazu Tazawa
Nominee Director of NIPRO Corporation

Mr. Toshikazu Tazawa is a seasoned professional and expert in the medical device manufacturing sector, bringing decades of international operational expertise from his extensive career with Nipro Corporation, Japan. Mr. Tazawa graduated in Civil Engineering from the Akita Prefectural Odate Technical Institute, Japan. His career with Nipro began in 1986 at the Odate Factory's Engineering Division.

His professional journey demonstrates a commitment to operational excellence and quality control across Asia:

  • Thailand (1989–2015): Served a long tenure as Deputy Manager of Production at Nipro (Thailand) Corporation Limited.
  • Indonesia (2015–2018): Joined PT. Nipro Indonesia Jaya as Deputy Factory Manager.
  • Thailand (2018–2025): Returned to Nipro (Thailand), serving as Manager of the Quality Conservation Department and later as Manager of Production.

With vast global experience in Nipro's business arena, Mr. Tazawa now holds a pivotal strategic role in Bangladesh. He is currently appointed as the Nominee Director of JMI Syringes & Medical Devices Limited on behalf of Nipro Corporation, Osaka, Japan, and concurrently serves as the Head of Operation for both JMI Syringes & Medical Devices Limited and Nipro JMI Company Limited.

Mr. Seigo Tsuchiya
Nominee Director
Mr. Seigo Tsuchiya
Nominee Director of NIPRO Corporation

Mr. Seigo Tsuchiya is a global business strategist and experienced leader in the medical and surgical devices sector. With a robust career spanning over two decades, he currently serves as a key decision-maker within the Global Business Department of Nipro Corporation.

Mr. Tsuchiya holds both a Bachelor of Economics from Nihon University, Japan (1997), and an MBA from Nanyang Technological University (2012). His career demonstrates a strong international focus:

  • Early Career (1998–2007): Began his professional life at Terumo Corporation, Tokyo, Japan.
  • Nipro Asia & Middle East (2007–Present): Joined Nipro ASIA PTE LTD. (Singapore) in 2007, serving as Area Manager and later as Deputy Section Manager of the Asia-Middle East Section, Global Sales Department.
  • Managing Director, UAE (2012–2015): Assigned as Managing Director of Nipro Middle East FZE.
  • Managing Director, Singapore (2015–Present): Transferred back to Nipro ASIA PTE LTD., where he currently serves as Managing Director.

He is appointed as a Nominee Director of JMI Syringes & Medical Devices Limited and Nipro JMI Marketing Limited in Bangladesh, representing Nipro Corporation, Osaka, Japan.

Mr. Kunio Takamido
Nominee Director
Mr. Kunio Takamido
Nominee Director of NIPRO Corporation

Mr. Kunio Takamido is a highly experienced professional specializing in global business development, sales, and marketing within the medical technology sector. His career trajectory showcases a strong technical foundation combined with international executive leadership across multiple continents.

Mr. Takamido holds both a BSc Engineering in Mechanical and an MSc in Systems Engineering from the prestigious Nagoya Institute of Technology, Japan (2000 and 2002, respectively). His career with Nipro Corporation is marked by significant international assignments:

  • Nipro Corporation, Japan (2002–2009): Began in the Shipping division and was actively engaged with the North & South America Sales section.
  • Nipro Medical Corporation, U.S.A. (2010–2020): Served a decade in the United States, starting as New Business Development Manager and culminating as Senior Director, New Business Development and Operation.
  • Nipro JMI Medical Ltd., Bangladesh (2020–2023): Served as Executive Director of Sales & Marketing in Dhaka, driving key strategic growth in the region.
  • Nipro Corporation, Japan (July 2023–Present): Serves as General Manager, Nipro Brand Sales, within the Sales Headquarter, Global Division.

He serves as a Nominee Director of JMI Syringes & Medical Devices Ltd. in Bangladesh, representing Nipro Corporation, leveraging his high-level international perspective.

Mr. Kazuhiko Fujishima
Nominee Director
Mr. Kazuhiko Fujishima
Nominee Director of NIPRO Corporation

Mr. Kazuhiko Fujishima is a highly distinguished executive and expert in global production and manufacturing excellence within the medical and surgical devices sector. With a career spanning four decades at Nipro Corporation, he is a key decision-maker in the Global Production Department.

Mr. Fujishima holds a B.E. in Mechanical Engineering Production from Akita University, Japan (1985). His extensive career with Nipro is defined by technical leadership, quality, and executive management across Asia:

  • Long-Term Service (1985–2014): Spent the first three decades of his career at the Nipro Corporation Odate Factory, building a deep foundation in manufacturing operations.
  • International Management (2014–2015): Served as Deputy General Manager Factory at PT. Nipro Indonesia Jaya.
  • Quality Leadership (2015–2022): Returned to the Odate Factory as General Manager of the Quality Assurance Department.
  • Executive Presidency (2022–2024): Led as President of Nipro Thailand Corporation Ltd.
  • Nipro Corporation (2025–Present): Serves as Senior Executive Officer, Global Production Division.

He serves as a Nominee Director of JMI Syringes & Medical Devices Ltd. in Bangladesh on behalf of Nipro Corporation, Osaka, Japan, guiding strategic production and quality initiatives.

Mr. Yoshinori Ishikawa
Nominee Director
Mr. Yoshinori Ishikawa
Nominee Director of NIPRO Corporation

Mr. Yoshinori Ishikawa is a seasoned financial and strategic professional with specialized expertise in corporate planning, accounting, and business systems optimization. His career includes over two decades in diverse finance roles within the Panasonic Group before transitioning to a key strategic position at Nipro.

Mr. Ishikawa holds a Bachelor of Business, Faculty of Economics from Sophia University, Japan (1994). His financial and planning experience spans across the Matsushita/Panasonic Group:

  • Early Career (1994–2008): Began in the CRT Business Division of Matsushita Electric Industrial Co. Ltd.
  • Accounting & Finance Leadership (2008–2024): Held successive management roles including Manager of the Welding Systems Accounting Section at Panasonic Smart Factory Solutions Co. Ltd. and Senior Manager of the Fixed Asset Accounting Department at Panasonic Financial & HR Pro Co. Ltd.
  • Plant Finance (2024–2025): Served as Manager of the Osaka Plant Accounting Section for Panasonic Energy Co. Ltd.
  • Nipro Corporation (2025–Present): Serves as Manager of the Corporate Planning Division.

He has been appointed as a Nominee Director of JMI Syringes & Medical Devices Limited in Bangladesh, representing Nipro Corporation, Osaka, Japan.

Mr. Hiromasa Wakatake
Nominee Director
Mr. Hiromasa Wakatake
Nominee Director of NIPRO Corporation

Mr. Hiromasa Wakatake is a dynamic, internationally experienced professional specializing in corporate finance and strategic planning. Since joining Nipro Corporation in 2011, he has rapidly advanced through key finance and management roles across three continents.

Mr. Wakatake holds a Bachelor of Economics from Hosei University, Japan (2011). His career path showcases strategic financial and administrative leadership within the Nipro Group:

  • Corporate Planning Foundation (2011–2015): Began his career in the Corporate Planning Division at Nipro Corporation's headquarters in Osaka.
  • Asia Leadership (2015–2020): Served as Finance Controller for Nipro JMI Pharma Limited & Nipro JMI Company Limited in Bangladesh, and later as Manager of the Administration Department at Nipro Thailand Corporation Limited.
  • Americas Finance Director (2020–2024): Elevated to Director of Finance at Nipro Medical Corporation in Miami, USA.
  • Nipro Corporation (March 2024–Present): Returned to Corporate Planning Division at Nipro Corporation, Osaka.

He serves as a Nominee Director of JMI Syringes & Medical Devices Limited in Bangladesh, representing Nipro Corporation.

Mr. Hiroshi Saito
Nominee Director
Mr. Hiroshi Saito
Nominee Director of NIPRO Corporation

Mr. Hiroshi Saito is a highly versatile and internationally accomplished executive with specialized expertise in global business administration, finance, and strategic planning. His career features a long, progressive tenure across multiple continents before transitioning to a key leadership role in the medical devices sector.

Mr. Saito holds a degree in Business Administration from Washington State University, USA (1997).

Global Leadership at NTT DOCOMO (1997–2020)
Mr. Saito spent over two decades with NTT DOCOMO, Inc., holding increasingly senior international and financial roles:

  • Americas (2004–2008): Served as Finance Manager for NTT DOCOMO, USA, Inc.
  • Asia Pacific (2011–2015): Held leadership positions at the Hanoi Representative Office (Vice Representative) and as Deputy Managing Director of NTT DOCOMO Singapore PTE. Ltd.
  • Europe & South America (2015–2019): Managed European Business from the Global Business Division and served as Administration Manager in Brazil.

After joining Nipro Corporation in Osaka in 2021 as Deputy Manager in Corporate Planning, Mr. Saito transitioned to Bangladesh where he currently serves as Executive Director, Finance & Accounts of JMI Syringes & Medical Devices Limited, and has been appointed as a Nominee Director representing Nipro Corporation, Osaka, Japan.

Mr. Muhammod Mustafizur Rahman
Independent Director
Mr. Muhammod Mustafizur Rahman
Independent Director

Mr. Mustafizur Rahman is a highly experienced and skilled banking professional who brings a wealth of financial knowledge to the Board as an Independent Director. Mr. Rahman holds an M.A. degree in Economics from the University of Rajshahi.

His distinguished career in the financial sector spans over 34 years at Janata Bank, one of the largest state-owned commercial banks in Bangladesh. During his extensive tenure, he served in various critical capacities, culminating in the senior executive role of Deputy General Manager.

Leveraging his deep operational and managerial expertise in banking, Mr. Rahman was re-appointed as an Independent Director of JMI Syringes & Medical Devices Ltd. for a three-year term, effective December 21, 2023. His valuable insights are instrumental in guiding the company's governance and strategic financial oversight.

Mrs. Jasmin Akter FCS
Independent Director
Mrs. Jasmin Akter FCS
Independent Director

Mrs. Jasmin Akter is a highly accomplished corporate governance expert and compliance specialist, bringing specialized statutory and regulatory oversight to the Board as an Independent Director. She holds an M.Com in Management from National University and possesses several key professional qualifications:

  • Fellow Chartered Secretary (FCS): Qualified from the Institute of Chartered Secretaries of Bangladesh (ICSB) in 2011.
  • Income Tax Practitioner (ITP) and Registered VAT Advisor under the National Board of Revenue (NBR).

Mrs. Akter has built a strong reputation over the last 10 years for her dedicated work in corporate compliance. She is the Managing Partner of Jasmin Associates, Chartered Secretaries (established in 2018), and is widely engaged by listed companies in Bangladesh to provide services as a Compliance Auditor, Independent Scrutinizer, and Secretarial Practice Consultant.

In addition to her role at JMI Syringes & Medical Devices Ltd., she serves as an Independent Director of Far East Knitting & Dyeing Industries PLC. Mrs. Akter was appointed as an Independent Director of JMI for a three-year term, effective September 29, 2025.

Top